LABVOLUTION 2019, 21 - 23 May
Homepage>Conference program >The European Nanomedicine-Characterisation-Laboratory (EU-NCL)
LabUSER Exhibitor's Forum

The European Nanomedicine-Characterisation-Laboratory (EU-NCL)

Location & Language


English, German

Event Details

Type of event



Applications/Research Biotechnology, Applications/Research Chemical, Pharmaceutical & Food Industries, Environmental Sector, Emerging Technologies

Event Host

Missed the Event?

So far no information materials were provided for this event. Please contact the organizer directly for further information.


In 2015 seven research centers in Europe started to build up the European Nano-Medicine Characterisation Laboratory (EU-NCL). In close collaboration with the US-NCL counterpart already in operation for ten years they established physicochemical and toxicological test systems for pre-clinical characterisation of nanomaterials dedicated for use in medicinal products and devices. Since January 2017 the EU-NCL is up and running ready to characterise nanomaterials developed by European researchers and companies. Since it is funded by the European Commission the service is at no cost for all users. More information about the involved partners, the available test systems and the access conditions can be found at <a href="" target="_blank"></a> and at booth B08 in Hall 20.


  Klaus-Michael Weltring

Klaus-Michael Weltring

Gesellschaft für Bioanalytik

Dr. Klaus-Michael Weltring is a molecular biologist by training with a PhD and a Habilitation degree from the University of Münster. Since 2001 he is the managing director of bioanalytik-muenster responsible ...

Go to profile

Stored items


Server communication error: Item could not be saved.